The Supreme Court, the Federal Circuit and the Second Circuit over the past year have issued major decisions in the fields of induced infringement (Akamai-McKesson); the patentability of medical diagnostics (Mayo Collaborative Services) and isolated DNA (Myriad Genetics); and the ability to protect color in the fashion world (Louboutin). In this term, the Supreme Court may hear cases involving pay-for delay settlements in ANDA litigation (Merck K-Pur) and others. Anthony Lo Cicero of Amster, Rothstein & Ebenstein LLP discusses these cases and their potential implications, in this edition of the Celesq®-West LegalEdcenter IP Master Series.